Hong Kong-listed traditional Chinese medicine stocks strengthened, with Luye Pharma rising more than 6%.

Gelonghui, July 13 | Traditional Chinese medicine-related stocks in the Hong Kong market rose collectively, with Weiyuantang up 12%, Luye Pharma gaining over 6%, China Traditional Chinese Medicine and Tongrentang Technology rising more than 2%, and Tongrentang International, Shennongweiyao, Kangchen Pharmaceutical, and Baiyunshan all increasing by over 1%.

Gelonghui FinanceJul 13 10:39

Biopharmaceuticals: Innovation-driven industry trends are clear, with international expansion and commercial insurance offering breakthrough opportunities.

In the short term, healthcare cost containment and anti-corruption efforts in the medical sector have exerted some impact on healthcare demand, while innovative payment models, commercial insurance formularies, and off-hospital care settings may drive industry improvements. Although geopolitical tensions and shifts in liquidity have triggered a temporary pullback in the innovative drug sector and related industries, the long-term trends of innovation and international expansion remain clear, and the current correction presents medium- to long-term investment opportunities. In the second half of 2026, we continue to recommend a barbell strategy: one end focused on innovation and internationalization opportunities, and the other anchored by traditional, stable dividend-paying assets. The development trajectory of the innovative drug industry chain is clear, and order trends in the pharmaceutical supply chain remain robust. Despite short-term pressures on the innovative drug sector stemming from macroeconomic co

CICC InsightsJul 1 10:08

China TCM Sets June 2026 AGM to Vote on Board and Auditor Reappointment

TipRanksMay 29 17:17

What cyclical recovery opportunities remain at present?

According to a report by Guolian Minsheng, the core of a turnaround from distress lies in the dual resonance between the 'financial reporting cycle' and the 'industry life cycle.' In terms of sector distribution, the 22 selected industries are primarily concentrated in four major sectors: cyclicals (polyurethane, raw materials supply chain services, coking coal), manufacturing (inverters, photovoltaic cells and modules, defense electronics), consumer goods (refrigerators and washing machines, footwear and headwear, traditional Chinese medicine, active pharmaceutical ingredients, etc.), and TMT (optical components, display panels, etc.).

wallstreetcnMay 25 17:25

H-share Announcements | China Jinmao achieved a cumulative contracted sales amount of 31.234 billion yuan in the first four months, representing a year-on-year increase of 23.44%.

Tuya Inc reported a net profit of US$15.8 million in the first quarter, representing a year-on-year increase of 43.2%. Revenue from its AI business grew by 16.9%, emerging as a new growth driver. China Jinmao achieved cumulative contracted sales of RMB31.234 billion in the first four months, marking a year-on-year increase of 23.44%.

Zhitong FinanceMay 12 09:05

China Traditional Chinese Medicine (00570.HK): The 3.1 category of ancient classic formula compound preparations, Shaoyao Gancao Tang Granules and Taohex Qi Tang Granules, have been approved for market launch.

Gelonghui, May 11th: China Traditional Chinese Medicine (00570.HK) announced that two subsidiaries of the company, Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd. and Guangdong Yifang Pharmaceutical Co., Ltd., have independently developed compound formulations of classical traditional Chinese medicine prescriptions classified as Type 3.1 – Shaoyao Gancao Tang Granules and Taohex Chengqi Tang Granules. These products have recently been granted drug registration certificates by the National Medical Products Administration of China and have been officially approved for market launch. The prescription for Shaoyao Gancao Tang Granules originates from the Treatise on Cold Damage Disorders authored by Zhang Zhongjing during the Eastern Han Dynasty. Modern clinical studies have demonstrated that Shaoyao Gancao Tang has significant therapeutic effects on conditions such as neck, shoulder, waist, and leg pain, gastrointestinal diseases, neurological disorders, and dermatological conditions.

Gelonghui FinanceMay 11 18:02